Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Seegene gets $4.8m order for supplying Covid-19 diagnostic kits to Kuwait Seegene, a South Korean molecular diagnostics company has been given an order worth more than $4.8 million for… byPallavi MadhirajuMay 18, 2021
